Home > Resources > CME Activities
The Association of Community Cancer Centers and Medscape Oncology are pleased to provide an online educational initiative that offers a community provider perspective about important cancer treatment and care issues, as well as emerging data and treatment strategies presented at scientific meetings, such as those of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).
Single vs Dual HER2 Blockade for Metastatic HER2—Positive Breast Cancer
Click to participate
Released: 12/18/2013; Valid for credit through 12/18/2014
This activity is intended for oncologists, obstetricians/gynecologists, and other healthcare professionals who treat and manage patients with breast cancer.
The goal of this activity is to discuss the changing standard of care for patients with metastatic HER2-positive breast cancer.
Howard A. Burris III, MD
George Somlo, MD
Physicians – maximum of 1.25 AMA PRA Category 1 Credit(s)™
This activity is supported by an independent educational grant from Genentech.